Ethnic differences in bone and mineral metabolism in healthy people and patients with CKD

Carregando...
Imagem de Miniatura
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Citação
KIDNEY INTERNATIONAL, v.85, n.6, p.1283-1289, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Several studies have shown racial differences in the regulation of mineral metabolism, in the acquisition of bone mass and structure of individuals. In this review, we examine ethnic differences in bone and mineral metabolism in normal individuals and in patients with chronic kidney disease. Black individuals have lower urinary excretion and increased intestinal calcium absorption, reduced levels of 25(OH)D, and high levels of 1.25(OH)(2)D and parathyroid hormone (PTH). Body phosphorus concentration is higher and the levels of FGF-23 are lower than in whites. Mineral density and bone architecture are better in black individuals. These differences translate into advantages for blacks who have stronger bones, less risk of fractures, and less cardiovascular calcification. In the United States of America, the prevalence of kidney disease is similar in different ethnic groups. However, black individuals progress more quickly to advanced stages of kidney disease than whites. This faster progression does not translate into increased mortality, higher in whites, especially in the first year of dialysis. Some ethnicity-related variations in mineral metabolism persist when individuals develop CKD. Therefore, black patients have lower serum calcium concentrations, less hyperphosphatemia, low levels of 25(OH)D, higher levels of PTH, and low levels of FGF-23 compared with white patients. Bone biopsy studies show that blacks have greater bone volume. The rate of fractures and cardiovascular diseases are also less frequent. Further studies are required to better understand the cellular and molecular bases of these racial differences in bone mineral metabolism and thus better treat patients.
Palavras-chave
bone histomorphometry, bone mineral density, chronic kidney disease, ethnic differences, mineral metabolism, vascular calcification
Referências
  1. ABRAMS SA, 1995, J BONE MINER RES, V10, P829
  2. Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618
  3. Arunabh S, 2002, METABOLISM, V51, P180, DOI 10.1053/meta.2002.29984
  4. Bachrach LK, 1999, J CLIN ENDOCR METAB, V84, P4702, DOI 10.1210/jc.84.12.4702
  5. Ball AM, 2002, JAMA-J AM MED ASSOC, V288, P3014, DOI 10.1001/jama.288.23.3014
  6. BELL NH, 1985, J CLIN INVEST, V76, P470, DOI 10.1172/JCI111995
  7. Bellasi A, 2008, ATHEROSCLEROSIS, V197, P242, DOI 10.1016/j.atherosclerosis.2007.03.047
  8. Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2
  9. Bosworth C, 2013, CLIN ENDOCRINOL, V79, P429, DOI 10.1111/cen.12163
  10. Braun M, 2007, AM J CLIN NUTR, V85, P1657
  11. Broadus Arthur E., 1993, P41
  12. Cauley JA, 2011, J BONE MINER RES, V26, P2378, DOI 10.1002/jbmr.449
  13. Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624
  14. CLEMENS TL, 1982, LANCET, V1, P74
  15. Cosman E, 1997, J BONE MINER RES, V12, P958
  16. Dalal M, 2011, EUR J ENDOCRINOL, V165, P797, DOI 10.1530/EJE-11-0577
  17. Daniels ED, 1997, OSTEOPOROSIS INT, V7, P105, DOI 10.1007/BF01623684
  18. Derose SF, 2013, AM J KIDNEY DIS, V62, P236, DOI 10.1053/j.ajkd.2013.01.019
  19. Dos Reis LM, 2007, J BONE MINER METAB, V25, P400, DOI 10.1007/s00774-007-0778-4
  20. Ennis J, 2012, NEPHROL DIAL TRANSPL, V27, P2847, DOI 10.1093/ndt/gfs080
  21. Freedman BI, 2010, J CLIN ENDOCR METAB, V95, P1076, DOI 10.1210/jc.2009-1797
  22. Freedman BI, 2012, NAT REV NEPHROL, V8, P459, DOI 10.1038/nrneph.2012.112
  23. Freercks R, 2012, NEPHROLOGY, V17, P607, DOI 10.1111/j.1440-1797.2012.01612.x
  24. FULEIHAN GEH, 1994, J CLIN ENDOCR METAB, V79, P1642, DOI 10.1210/jc.79.6.1642
  25. Gallagher JC, 2009, J CLIN ENDOCR METAB, V93, P1137
  26. GHANDURMNAYMNEH L, 1986, AM J PATHOL, V125, P292
  27. Gupta A, 2000, J AM SOC NEPHROL, V11, P330
  28. Gutierrez OM, 2011, OSTEOPOROSIS INT, V22, P1745, DOI 10.1007/s00198-010-1383-2
  29. Gutierrez OM, 2010, NEPHROL DIAL TRANSPL, V25, P3970, DOI 10.1093/ndt/gfq316
  30. Gutierrez OM, 2008, KIDNEY INT, V73, P956, DOI 10.1038/ki.2008.4
  31. Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130
  32. Han ZH, 1996, J BONE MINER RES, V11, P1967
  33. Han ZH, 1997, J BONE MINER RES, V12, P498, DOI 10.1359/jbmr.1997.12.4.498
  34. Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040
  35. Ix JH, 2011, AM J KIDNEY DIS, V58, P737
  36. Jablonski NG, 2012, PHILOS T R SOC B, V367, P785, DOI 10.1098/rstb.2011.0308
  37. Jackman LA, 1997, AM J CLIN NUTR, V66, P327
  38. Jovanovich A, 2012, CLIN J AM SOC NEPHRO, V7, P640, DOI 10.2215/CJN.07020711
  39. Jung JS, 2009, J CLIN ENDOCR METAB, V94, P1042, DOI 10.1210/jc.2008-1861
  40. Kalantar-Zadeh K, 2010, SEMIN DIALYSIS, V23, P586, DOI 10.1111/j.1525-139X.2010.00795.x
  41. Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3
  42. Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224
  43. Kestenbaum BR, 2009, KIDNEY INT, V76, P991, DOI 10.1038/ki.2009.298
  44. Kovesdy CP, 2013, AM J KIDNEY DIS, V62, P228, DOI 10.1053/j.ajkd.2012.12.012
  45. Kritchevsky SB, 2012, J CLIN ENDOCR METAB, V97, P4156, DOI 10.1210/jc.2012-1551
  46. Lau EMC, 2001, OSTEOPOROSIS INT, V12, P239, DOI 10.1007/s001980170135
  47. Leder BZ, 2007, J CLIN ENDOCR METAB, V92, P3453, DOI 10.1210/jc.2006-2695
  48. Looker AC, 2013, J BONE MINER RES, V28, P997, DOI 10.1002/jbmr.1828
  49. Looker AC, 2012, OSTEOPOROSIS INT, V23, P771, DOI 10.1007/s00198-011-1623-0
  50. Malluche HH, 2011, J BONE MINER RES, V26, P1368, DOI 10.1002/jbmr.309
  51. Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414
  52. Na T, 2009, AM J PHYSIOL-RENAL, V296, pF1042, DOI 10.1152/ajprenal.90771.2008
  53. Nakamura K, 2000, INT J VITAM NUTR RES, V70, P287, DOI 10.1024/0300-9831.70.6.287
  54. Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187
  55. Norris SA, 2008, PRIMER METABOLIC BON, P80, DOI 10.1002/9780470623992.ch15
  56. Parfitt AM, 1997, J BONE MINER RES, V12, P1864, DOI 10.1359/jbmr.1997.12.11.1864
  57. Parisien M, 1997, J BONE MINER RES, V12, P948, DOI 10.1359/jbmr.1997.12.6.948
  58. Parker BD, 2010, ANN INTERN MED, V152, P640, DOI [10.7326/0003-4819-152-10-201005180-00004, 10.1059/0003-4819-152-10-201005180-00004]
  59. Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357
  60. Qiu SJ, 2006, BONE, V38, P130, DOI 10.1016/j.bone.2005.07.004
  61. Register TC, 2013, J CLIN ENDOCR METAB, V98, pE60, DOI 10.1210/jc.2012-3038
  62. ROSS PD, 1991, AM J EPIDEMIOL, V133, P801
  63. Sawaya BP, 2003, KIDNEY INT, V64, P737, DOI 10.1046/j.1523-1755.2003.00129.x
  64. SCHNITZLER CM, 1990, BONE MINER, V10, P183, DOI 10.1016/0169-6009(90)90261-D
  65. Schnitzler CM, 2006, CALCIFIED TISSUE INT, V79, P373, DOI 10.1007/s00223-006-0053-z
  66. Shin SK, 1999, PERITON DIALYSIS INT, V19, pS402
  67. Sowers M, 2003, J CLIN ENDOCLIN META, V88, P4901
  68. Sowers MR, 2013, J CLIN ENDOCR METAB, V98, P2854, DOI 10.1210/jc.2012-4113
  69. Stehman-Breen CO, 1999, AM J KIDNEY DIS, V33, P947
  70. Thorson S, 2013, J BONE MINER RES, V28, P2008, DOI 10.1002/jbmr.1929
  71. U.S. Renal Data System, 2009, USRDS 2009 ANN DAT R
  72. Wang XF, 2005, BONE, V36, P978, DOI 10.1016/j.bone.2004.11.015
  73. WEINSTEIN RS, 1988, NEW ENGL J MED, V319, P1698, DOI 10.1056/NEJM198812293192603
  74. Wolf M, 2008, J AM SOC NEPHROL, V19, P1379, DOI 10.1681/ASN.2007091002
  75. Xu L, 1996, Am J Epidemiol, V144, P901
  76. Zadshir A., 2005, ETHN DIS S5, V15, P97